Author

T.-a. Nakada

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:virus· 1

Frequent Co-Authors

A. Kaneda· 2 shared A. Takaori-Kondo· 2 shared I. Kimura· 2 shared K. Shirakawa· 2 shared K. Uriu· 2 shared The Genotype to Phenotype Japan (G2P-Japan) Consortium· 2 shared D. Yamasoba· 1 shared E. P. Butlertanaka· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Kaneda

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Virological characteristics of SARS-CoV-2 BA.2 variant

D. Yamasoba, I. Kimura, H. Nasser, Y. Morioka, N. Nao, J. Ito, K. Uriu, M. Tsuda, J. Zahradnik, K. Shirakawa, R. Suzuki, M. Kishimoto, Y. Kosugi, K. Kobiyama, T. Hara, , Sawa

This study compares the virological characteristics of SARS-CoV-2 BA.2 and BA.1 variants, finding BA.2 has higher transmissibility, different antigenicity, greater replicative capacity, and higher pathogenicity in hamsters.

bioRxiv · Feb 14, 2022Microbiology

Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera

K. Uriu, I. Kimura, K. Shirakawa, A. Takaori-Kondo, T.-a. Nakada, A. Kaneda, The Genotype to Phenotype Japan (G2P-Japan) Consortium, S. Nakagawa, K. Sato

This study shows that Mu variant is highly resistant to neutralization by convalescent and vaccine sera compared to other variants.

bioRxiv · Sep 6, 2021Microbiology